[Contraception with Depo-Provera. Report of a series of 930 women].
In this study, Dépo-Provéra was evaluated in 930 women. It is a retrospective longitudinal bicentric study: We revealed the following results: The average age is 30.8 years. 66.6% the women have between 1 and 3 children. The nulliparous represent 17%. In 84.3%, it is the first used contraceptive method. The first injection was done in the post abortion in 65.3% of the cases. Pearl index is 0.46. Thus, the efficacy level is 99.54%. Amenorrhea is the most frequent trouble; its incidence within a year is 52.3%. It the first cause of abandon. The other troubles of the cycle disappear within 12 months. The acceptability is 34.8% year women.
Mahjoub
S
S
Service de Gynécologie, Obstétrique C, CMNT, Tunis.
Lebbi
I
I
Dakhli
R
R
Smaïli
L
L
Ben Hmjd
R
R
Ben Romdhane
M
M
Zouari
F
F
Hamzaoui
R
R
D000028:Abortion, Induced; D000293:Adolescent; D000328:Adult; D000568:Amenorrhea / Q000139:chemically induced; D003271:Contraceptive Agents, Female / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D005260:Female; D006801:Humans; D008137:Longitudinal Studies; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D008597:Menstrual Cycle; D008875:Middle Aged; D010349:Patient Compliance; D012189:Retrospective Studies
D003271:Contraceptive Agents, Female; D017258:Medroxyprogesterone Acetate